Attenuation of risperidone-induced hyperprolactinemia with the addition of aripiprazole

J Clin Pharm Ther. 2009 Oct;34(5):595-8. doi: 10.1111/j.1365-2710.2008.01009.x.

Abstract

Hyperprolactinemia can be a complication of conventional neurolepics as well as risperidone. We report the third case of attenuation of risperidone-induced hyperprolactinemia by aripiprazole.

Publication types

  • Case Reports

MeSH terms

  • Aripiprazole
  • Humans
  • Hyperprolactinemia / chemically induced
  • Hyperprolactinemia / drug therapy*
  • Male
  • Middle Aged
  • Piperazines / therapeutic use*
  • Quinolones / therapeutic use*
  • Receptors, Dopamine D2 / drug effects
  • Risperidone / adverse effects*

Substances

  • Piperazines
  • Quinolones
  • Receptors, Dopamine D2
  • Aripiprazole
  • Risperidone